Evidence map›Paper›PMID 42083303›Full record

ArticleChemSusChem2026

Safe and Sustainable by Design (SSbD) Synthesis of Food and Personal Care Ingredients by Mechanochemistry.

Rubén Solórzano-Rodríguez, Nicolas Fantozzi, Andrea Casagrande, Christos M Chatzigiannis, Corentin Bordier, Pietro Rando, Evelina Colacino

Abstract read
In one paragraph

Article in ChemSusChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rubén Solórzano-RodríguezICGM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.ORCID 0000-0001-7821-7144
Nicolas FantozziICGM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.
Andrea CasagrandeICGM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.
Christos M ChatzigiannisICGM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.
Corentin BordierICGM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.
Pietro RandoCRB Benelux BV, Maastricht, The Netherlands.
Evelina ColacinoICGM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.ORCID 0000-0002-4558-2898

Funding

Campus France - French Embassy in EstoniaEuropean Cooperation in Science and Technology CA18112European Health and Digital Executive Agency 101057286Région Occitanie Pyrénées-Méditerranée Pre-Maturation 2020 - MECHAPI grant (ESRPREMAT - 00262)
6 · The paper itself

Abstract

The preparation of perillartine, a potent marketed sweetener, and N-tert-butyl-α-phenylnitrone (PBN), a most commonly used free-radical spin-trap used in personal care formulation, endowed with antioxidant, neuroprotective, and anti-aging properties, was studied by vibrating and planetary ball-milling. The reactivity in polymeric jars, such as PTFE and in-house made polyoxymethylene (POM), was evaluated and compared to the most commonly used stainless steel and zirconium oxide milling media. This investigation revealed an insightful correlation while also accounting for the energy involved in each transformation. Assessment of the processes by green chemistry metrics and tools (e.g., Chem21, DOZN 3.0 and EcoScale) showed that mechanochemical approaches offer a Safe and Sustainable by Design (SSbD) approach also complying with the IUPAC guiding principles of a responsible chemistry. The reduced solvent consumption, the simplified purification procedures, and lower associated environmental and safety hazards are strongly aligned with the green chemistry principles.

Indexed as

FoodGreen Chemistry TechnologyMechanical Phenomenaactive ingredientsbiomass transformationgreen chemistry metricsmechanochemistrypolymeric jars

Identifiers

PMID42083303
PMCPMC13139749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.